Memo Therapeutics raised €26M in a Series C round in Nov 2023. The company is based in Zurich, Switzerland. Investors in the round: Adjuvant Capital, Fresenius Medical Care Ventures, GF Group Holding and 6 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
